Myelosafe PG Tablet

Przegląd produktu

About Myelosafe PG Tablet

Myelosafe PG Tablet is a medication containing the active ingredient lenalidomide, classified as Thalidomide Analog. Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, various indolent lymphomas, and myelodysplastic syndromes (MDS). For multiple myeloma, it is a first-line treatment, and is given with dexamethasone. It is taken by mouth.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Lenalidomide is a thalidomide analogue indicated for the treatment of adult patients with: Multiple myeloma (MM), in.
• Used for: MM, as maintenance following autologous hematopoietic stem cell transplantation (auto-HSCT) ( 1
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

lenalidomide, the active ingredient in Myelosafe PG Tablet, belongs to the Thalidomide Analog class. 1 INDICATIONS AND USAGE Lenalidomide is a thalidomide analogue indicated for the treatment of adult patients with: Multiple myeloma (MM), in combination with dexamethasone ( 1. 1 ). MM, as maintenance following autologous hematopoietic stem cell transplantation (auto-HSCT) ( 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Myelosafe PG Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Myelosafe PG Tablet for extended periods without medical advice.